This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Clough, D. W. Articles by Parkhurst, J. R. Search for Related Content PubMed PubMed Citation Articles by Clough, D. W. Articles by Parkhurst, J. R.

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1977 February; 11(2): 307-311
Copyright © 1977 American Society for Microbiology. All Rights Reserved.

Experimental Herpes Simplex Virus Type 1 Encephalitis: Treatment with 5-Trifluoromethyl-2'-Deoxyuridine

^* The Medical College of Wisconsin, Department of Microbiology, Milwaukee, Wisconsin 53233
The Midwest Childhood Cancer Center, Milwaukee, Wisconsin 53233

ABSTRACT

5-Trifluoromethyl-2'-deoxyuridine (F₃dThd) was evaluated for its neurotoxicity and for its ability to increase the life span of mice injected intracerebrally with herpes simplex virus type 1 (HSV-1) and F₃dThd simultaneously. F₃dThd showed no neurotoxicity at the highest concentration tested (100 mg/kg). Mice injected intracerebrally with HSV-1 died within 5 days postinfection. However, all mice injected concurrently with HSV-1 and 100 mg of F₃dThd per kg lived through the termination of the experiment (60 days). Protection of mice from HSV-1 encephalitis by F₃dThd has been shown to be dose dependent, with 100, 75, 50, and 25 mg of F₃dThd per kg yielding a survival rate of 100, 90, 50, and 10%, respectively. HSV-1 titers in mouse brains receiving HSV-1 and 100 mg of F₃dThd per kg concurrently were 100- to 1,000-fold lower at 2 to 4 days postinfection than control mice receiving HSV-1 alone. F₃dThd was shown not to stimulate interferon production. Encephalitis caused by a ribonucleic acid virus, encephalomyocarditis virus, was not modified by F₃dThd treatment.